Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsWith over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications. Highlights
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsDopamine receptors (DR), including D1-5 (also called DRD1-5), are originally identified to be the receptors for dopamine, an endogenous neurotransmitter that controls a variety of brain functions, including emotion, cognition, and movement. Furthermore, dopamine also plays a significant role in human placental endocrine function, and it has the ability to inhibit human placental lactogen (hPL) and human chorionic gonadotrophin production. As a G protein-coupled receptor member, DR is classified into D1-like (including DRD1 and DRD5) and D2-like (including DRD2, DRD3, and DRD4) families according to their coupled G proteins, Gαs or Gαi. It has been reported that dopamine receptors, particularly the D2-like receptors, have been implicated in the pathophysiology of many neurogenic diseases such as Parkinson and Alzheimer. And relevant agonists or antagonists have been used to target DR for therapy or modified to generate effective probes for live imaging.
Here, we give a comprehensive introduction for members of the DR family, including but not limited to dopamine D1 receptor, dopamine D2 receptor, and dopamine D3 receptor. To learn more detailed information, please click the links below.
Aided by our advanced Magic™ membrane protein production platform, Creative Biolabs is confident in offering diverse target membrane protein products in required formats using various strategies, such as detergent micelles, proteoliposomes, nanodiscs, lipoparticles, polymers, stable cell line.
Moreover, our Magic™ membrane protein antibody discovery platform can help to discover antibodies against these targets, even fully humanized antibodies, by various approaches such as hybridoma technology, phage display technology. We also present DNA immunization service for anti-membrane protein antibody development. To get more detailed information, please feel free to contact us.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
